These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25655053)

  • 1. Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Dickinson JA; Winter AL; Drews SJ; Fonseca K; Charest H; Gubbay JB; Petric M; Krajden M; Kwindt TL; Martineau C; Eshaghi A; Bastien N; Li Y
    Euro Surveill; 2015 Jan; 20(4):. PubMed ID: 25655053
    [No Abstract]   [Full Text] [Related]  

  • 2. Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013.
    Skowronski DM; Janjua NZ; De Serres G; Dickinson JA; Winter AL; Mahmud SM; Sabaiduc S; Gubbay JB; Charest H; Petric M; Fonseca K; Van Caeseele P; Kwindt TL; Krajden M; Eshaghi A; Li Y
    Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014.
    Skowronski D; Chambers C; Sabaiduc S; De Serres G; Dickinson J; Winter A; Fonseca K; Gubbay J; Charest H; Petric M; Krajden M; Mahmud S; Van Caeseele P; Kwindt T; Eshaghi A; Bastien N; Li Y
    Euro Surveill; 2014 Feb; 19(5):. PubMed ID: 24524234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020.
    Skowronski DM; Zou M; Sabaiduc S; Murti M; Olsha R; Dickinson JA; Gubbay JB; Croxen MA; Charest H; Jassem A; Krajden M; Bastien N; Li Y; De Serres G
    Euro Surveill; 2020 Feb; 25(7):. PubMed ID: 32098644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
    Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
    Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.
    Skowronski DM; Chambers C; Sabaiduc S; Dickinson JA; Winter AL; De Serres G; Drews SJ; Jassem A; Gubbay JB; Charest H; Balshaw R; Bastien N; Li Y; Krajden M
    Euro Surveill; 2017 Feb; 22(6):. PubMed ID: 28205503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants.
    Janjua NZ; Skowronski DM; De Serres G; Dickinson J; Crowcroft NS; Taylor M; Winter AL; Hottes TS; Fonseca K; Charest H; Drews SJ; Sabaiduc S; Bastien N; Li Y; Gardy JL; Petric M
    J Infect Dis; 2012 Jun; 205(12):1858-68. PubMed ID: 22492921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
    Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
    J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interim estimates of 2014/15 influenza vaccine effectiveness in preventing laboratory-confirmed influenza-related hospitalisation from the Serious Outcomes Surveillance Network of the Canadian Immunization Research Network, January 2015.
    McNeil SA; Andrew MK; Ye L; Haguinet F; Hatchette TF; ElSherif M; LeBlanc J; Ambrose A; McGeer A; McElhaney JE; Loeb M; MacKinnon-Cameron D; Sharma R; Dos Santos G; Shinde V;
    Euro Surveill; 2015 Feb; 20(5):21024. PubMed ID: 25677052
    [No Abstract]   [Full Text] [Related]  

  • 10. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study.
    Kissling E; Valenciano M; Larrauri A; Oroszi B; Cohen JM; Nunes B; Pitigoi D; Rizzo C; Rebolledo J; Paradowska-Stankiewicz I; Jiménez-Jorge S; Horváth JK; Daviaud I; Guiomar R; Necula G; Bella A; O'Donnell J; Głuchowska M; Ciancio BC; Nicoll A; Moren A
    Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019.
    Skowronski DM; Leir S; Sabaiduc S; Murti M; Dickinson JA; Olsha R; Gubbay JB; Croxen MA; Charest H; Chan T; Bastien N; Li Y; Krajden M; De Serres G
    Euro Surveill; 2019 Jan; 24(4):. PubMed ID: 30696523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
    Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
    Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection.
    Pebody R; Andrews N; McMenamin J; Durnall H; Ellis J; Thompson CI; Robertson C; Cottrell S; Smyth B; Zambon M; Moore C; Fleming DM; Watson JM
    Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results.
    Pebody RG; Warburton F; Ellis J; Andrews N; Thompson C; von Wissmann B; Green HK; Cottrell S; Johnston J; de Lusignan S; Moore C; Gunson R; Robertson C; McMenamin J; Zambon M
    Euro Surveill; 2015 Feb; 20(5):21025. PubMed ID: 25677050
    [No Abstract]   [Full Text] [Related]  

  • 15. Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012.
    Jimenez-Jorge S; de Mateo S; Pozo F; Casas I; Garcia Cenoz M; Castilla J; Gallardo V; Perez E; Vega T; Rodriguez C; Quinones C; Martinez E; Gimenez J; Vanrell J; Castrillejo D; Serrano M; Ramos J; Larrauri A
    Euro Surveill; 2012 Mar; 17(12):. PubMed ID: 22490308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
    Skowronski DM; Masaro C; Kwindt TL; Mak A; Petric M; Li Y; Sebastian R; Chong M; Tam T; De Serres G
    Vaccine; 2007 Apr; 25(15):2842-51. PubMed ID: 17081662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
    J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low vaccine effectiveness against influenza A(H3N2) virus among elderly people in Denmark in 2012/13--a rapid epidemiological and virological assessment.
    Bragstad K; Emborg H; Fischer TK; Voldstedlund M; Gubbels S; Andersen B; Molbak K; Krause T
    Euro Surveill; 2013 Feb; 18(6):. PubMed ID: 23410258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe.
    Kissling E; Rondy M;
    Euro Surveill; 2017 Feb; 22(7):. PubMed ID: 28230524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017.
    Sullivan SG; Chilver MB; Carville KS; Deng YM; Grant KA; Higgins G; Komadina N; Leung VK; Minney-Smith CA; Teng D; Tran T; Stocks N; Fielding JE
    Euro Surveill; 2017 Oct; 22(43):. PubMed ID: 29090681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.